A NTIPHOSPHOLIPID antibodies have been associated with a variety of clinical phenomena, including arterial and venous thrombosis, thrombocytopenia, and obstetric complications. The term “antiphospholipid syndrome”[1][1]is used to link a variety of thromboembolic events to antibodies against
No takes yet. Share an insight, caveat, or question.
Galli et al. (1999) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: